Hutchmed (China) Limited American Depositary Shares (HCM)
NASDAQ
Closed
Aug 24, 2026
Day's Range
12.0952 wk Range
9.77Overview - HCM - Hutchmed (China) Limited American Depositary Shares
Key Statistics
Valuation
Enterprise Value
927.51M
P/E (Trailing)
‪126.30‬
P/E (Forward)
‪51.80‬
PEG Ratio
‪51.80‬
Price / Sales (TTM)
‪3.99‬
Price / Book
‪1.74‬
EV / EBITDA
‪-45.21‬
Profitability
Gross Margin
‪23.08%‬
Profit Margin
‪3.25%‬
Operating Margin
‪0.31%‬
Return on Assets
‪-1.23%‬
Return on Equity
‪1.46%‬
Ownership
Shares Outstanding
859.74M
Float
104.58M
Short % of Shares Outstanding
‪0.17%‬
Held by Insiders
‪0.0089%‬
Held by Institutions
‪2.69%‬
Price stats
Beta
‪0.43‬
50-Day Avg
‪11.30‬
200-Day Avg
‪13.36‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
13 analysts
Average price target
‪$ 20.99‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - HCM - Hutchmed (China) Limited American Depositary Shares
Peers - HCM - Hutchmed (China) Limited American Depositary Shares
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NASDAQ.
- HCMNASDAQHutchmed (China) Limited American Depositary Shares2.19BMarket Cap-26.13%52-week change126.30P/E (Trailing)‪3.25%‬Profit Margin
- NBIXNASDAQNeurocrine Biosciences Inc.15.50BMarket Cap+12.18%52-week change22.34P/E (Trailing)‪20.91%‬Profit Margin
- ALALKSNASDAQAlkermes plc8.10BMarket Cap+40.00%52-week change127.18P/E (Trailing)‪3.96%‬Profit Margin
- LNTHNASDAQLantheus Holdings, Inc.6.52BMarket Cap+43.82%52-week change23.92P/E (Trailing)‪17.69%‬Profit Margin
- AMRXNASDAQAmneal Pharmaceuticals Inc.6.23BMarket Cap+48.19%52-week change37.60P/E (Trailing)‪5.04%‬Profit Margin
- KNKNSANASDAQKiniksa Pharmaceuticals International, plc6.16BMarket Cap+58.19%52-week change79.83P/E (Trailing)‪9.59%‬Profit Margin
- ALMNASDAQAlmonty Industries Inc.5.33BMarket Cap+76.82%52-week change84.14P/E (Trailing)‪125.23%‬Profit Margin
Profile Summary - HCM - Hutchmed (China) Limited American Depositary Shares
About
Hutchmed (China) Limited American Depositary Shares represent shares in HUTCHMED (China) Limited, an innovative, commercial-stage biopharmaceutical company. It specializes in the discovery, global development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases. The…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
